Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Initiates Coverage On Riverview Acquisition with Buy Rating, Announces Price Target of $15

Benchmark Initiates Coverage On Riverview Acquisition with Buy Rating, Announces Price Target of $15

Benchmark analyst Todd Brooks initiates coverage on Riverview Acquisition (NASDAQ:RVAC) with a Buy rating and announces Price Target of $15.

byBenzinga Newsdesk

July 22, 2022

1 minute read

Benchmark analyst Todd Brooks initiates coverage on Riverview Acquisition (NASDAQ:RVAC) with a Buy rating and announces Price Target of $15.

Piper Sandler Maintains Overweight on ServiceNow, Lowers Price Target to $550

By Benzinga Newsdesk

July 28, 6:39 AM

Piper Sandler analyst Rob Owens maintains ServiceNow (NYSE:NOW) with a Overweight and lowers the price target from $600 to $550.

NOW

Analyst Ratings

What Analysts Are Saying About Chord Energy Stock

By Benzinga Insights

June 3, 10:01 AM

9 analysts have expressed a variety of opinions on Chord Energy (NASDAQ:CHRD) over the past quarter, offering a…

CHRD

News

Why Meta Platforms Stock Is Rising

By Henry Khederian

July 28, 11:10 AM

Meta Platforms Inc (NASDAQ: META) shares are trading higher by 3.49% to $322.57 Friday morning on continued strength following the company's recent earnings report.

Why Are Nanobiotix Shares Plummeting Today?

By Vandana Singh

April 25, 11:18 AM

Nanobiotix (NASDAQ:NBTX) shares are trading lower after the company raised going concerns in its Q4 earnings release. The company noted…

NBTX

Benchmark Initiates Coverage On Riverview Acquisition with Buy Rating, Announces Price Target of $15

Related Posts

Piper Sandler Maintains Overweight on ServiceNow, Lowers Price Target to $550

What Analysts Are Saying About Chord Energy Stock

Why Meta Platforms Stock Is Rising

Why Are Nanobiotix Shares Plummeting Today?